Antigen expression determines adenoviral vaccine potency independent of IFN and STING signaling
Kylie M. Quinn(Monash University), Robert A. Seder(National Institutes of Health), Alfredo Nicosia(Ospedale Antonio Cardarelli), Stefano Colloca(RINA Consulting - Centro Sviluppo Materiali S.p.A. (Italy)), Lingshu Wang(National Institutes of Health), Andréia da Silva Costa(National Institute of Allergy and Infectious Diseases), Brenna J. Hill(National Institute of Allergy and Infectious Diseases), Geoffrey M. Lynn(National Institutes of Health), Daniel E. Zak(Center for Infectious Disease Research), Alan Aderem(Infectious Disease Research Institute), Emma Gostick(John Radcliffe Hospital), Ayako Yamamoto(National Institute of Allergy and Infectious Diseases), Ross Lindsay(National Institutes of Health), Jason G. Gall(GenVec), Mario Roederer(National Institutes of Health), David A. Price(University Hospital of Wales), Antonella Folgori, Cheng Cheng(Chinese Academy of Medical Sciences & Peking Union Medical College), Kathrin Kastenmüller(National Institute of Allergy and Infectious Diseases), Riccardo Cortese(Sigma Tau (Italy)), Patricia A. Darrah(National Institutes of Health)
Cited by 119
Related Papers
A human memory T cell subset with stem cell–like properties
|Nature Medicine|2011|2k
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
|Science|2010|1.8k
Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation
|Journal of Immunological Methods|2003|1.6k
T-cell quality in memory and protection: implications for vaccine design
|Nature reviews. Immunology|2008|1.6k